Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
World Diabetes Day: Celebrating Two Decades of Progress in Combating Diabetes and Its Complications in Iran Publisher



Bandarian F1 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, 3rd floor, No: 10, Next to Dr Shariati Hospital, Gomnam Highway, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2019


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Iran Diabetes Research Roadmap (Idrr) Study: An Overview, Iranian Journal of Public Health (2017)
2. Expression Level of Circulating Cell Free Mir-155 Gene in Serum of Patients With Diabetic Nephropathy, Clinical Laboratory (2019)
3. Iran Diabetes Research Roadmap (Idrr) Study; Gap Analysis of Diabetes Complications in Iran: A Review Article, Iranian Journal of Public Health (2017)
4. Iran Diabetes Research Roadmap (Idrr) Study; Research Gap in Gestational Diabetes in Iran: A Review Article, Iranian Journal of Public Health (2017)
5. An Overview of Diabetes Research Achievements During a Quarter of a Century in Diabetes Research Center, Journal of Diabetes and Metabolic Disorders (2021)
6. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
7. Achievements and Advances in Diabetes Research Over a Quarter of a Century: A Review of the Available Evidence, Iranian Journal of Diabetes and Metabolism (2021)
8. Ottawa Charter Framework As a Guide for Type 2 Diabetes Prevention and Control in Iran, Journal of Diabetes and Metabolic Disorders (2019)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (27)
Fatemeh Bandarian (20)
Other Related Docs
9. Prevalence of Smoking Among Iranian Adults: Findings of the National Steps Survey 2016, Archives of Iranian Medicine (2020)
10. Inequalities in the Prevalence, Diagnosis Awareness, Treatment Coverage and Effective Control of Diabetes: A Small Area Estimation Analysis in Iran, BMC Endocrine Disorders (2023)
11. Agtr1 Rs5186 Variants in Patients With Type 2 Diabetes Mellitus and Nephropathy, Meta Gene (2018)
12. Ldl-Cholesterol Measurement in Diabetic Type 2 Patients: A Comparison Between Direct Assay and Popular Equations, Journal of Diabetes and Metabolic Disorders (2017)
13. Endocrinology and Metabolism Institute Over Time: A Quarter of a Century of Experience, Iranian Journal of Diabetes and Metabolism (2021)
14. Iran Diabetes Research Roadmap (Idrr) Study; Analysis of Diabetes Comorbidity Studies in Iran: A Review Article, Iranian Journal of Public Health (2017)
15. Geographical, Gender and Age Inequalities in Non-Communicable Diseases Both at National and Provincial Levels in Iran, Journal of Diabetes and Metabolic Disorders (2021)
16. The Economic Burden of Smoking-Attribution and Years of Life Lost Due to Chronic Diseases in Mashhad, 2015-2016, International Journal of Preventive Medicine (2021)
17. Iran Diabetes Research Study; Knowledge Discovery in Diagnosis: A Scoping Review, Journal of Diabetes and Metabolic Disorders (2021)
18. Cardiometabolic Risk Factors Trend in Iranian Adults With Hypertension Over 15 Years: Findings of Nationwide Steps of 2007–2021, Journal of Diabetes and Metabolic Disorders (2024)
19. The First Nationally and Sub-Nationally Representative Non-Communicable Diseases Cohort Study in Iran: Iran Cohort Study (Ics) Protocol, Journal of Diabetes and Metabolic Disorders (2023)
20. Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients, Journal of Diabetes and Metabolic Disorders (2018)
21. Mapping Evidence of Iran Diabetes Research: Protocol for a Scoping Review, Journal of Diabetes and Metabolic Disorders (2022)
22. The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021, Journal of Diabetes and Metabolic Disorders (2023)
23. Endocrinology and Metabolism Research Institute From Inception to Maturity: An Overview of 25-Year Activity, Journal of Diabetes and Metabolic Disorders (2020)
24. Mapping Research in Diabetes Complications; a Scoping Review, Journal of Diabetes and Metabolic Disorders (2022)
25. Epidemiology of Diabetes in Iran: A Scoping Review of Studies Published During 2015–2019, Journal of Diabetes and Metabolic Disorders (2022)
26. National Innovation System for Diabetes and Metabolic Disorders Can Promote Biomedical Research Accountability; a Literature Review and Designing a Conceptual Framework, Journal of Diabetes and Metabolic Disorders (2021)
27. Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; the Results of the Steps of 2016, Archives of Iranian Medicine (2022)
28. Iran Diabetes Research Roadmap (Idrr) Study; Trends of Publications in Management of Diabetes in Iran: A Review Article, Iranian Journal of Public Health (2017)
29. Iran Diabetes Research Roadmap (Idrr) Study; Knowledge Gap in Genetic Research on Diabetes Mellitus in Iran: A Review Article, Iranian Journal of Public Health (2017)
30. Iran Diabetes Research Roadmap (Idrr): The Study Protocol, Journal of Diabetes and Metabolic Disorders (2016)
31. Estimation of Myocardial Infarction Death in Iran: Artificial Neural Network, BMC Cardiovascular Disorders (2022)
32. Patterns of Obesity and Overweight in the Iranian Population: Findings of Steps 2016, Frontiers in Endocrinology (2020)
33. Policy Implications for Diabetes Prevention and Control: An Experience From Iran, Medical Journal of the Islamic Republic of Iran (2022)
34. The Midwife's Role in Prevention of Non-Communicable Diseases in Iran, Journal of Education and Health Promotion (2021)
35. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)
36. Assessment and Prioritization of the Who Best Buys and Other Recommended Interventions for the Prevention and Control of Non-Communicable Diseases in Iran, BMC Public Health (2020)
37. Expression Level of Circulating Mir-93 in Serum of Patients With Diabetic Nephropathy; [Diyabetik Nefropati Hastalarinin Serumlarinda Serbest Mir-93 Ekspresyon Duzeyleri], Turkish Journal of Endocrinology and Metabolism (2018)
38. A Multi-Sectoral Approach to Combatting Non-Communicable Diseases: Iran’S Experience, Journal of Diabetes and Metabolic Disorders (2019)
39. Trend of Nutrition Research in Endocrine Disorders, Gaps, and Future Plans: A Collection of Experiences of an Endocrinology Research Institute, Journal of Diabetes and Metabolic Disorders (2021)
40. Developing an Organizational Capacity Assessment Tool and Capacity-Building Package for the National Center for Prevention and Control of Noncommunicable Diseases in Iran, PLoS ONE (2023)
41. The Burden of Type 2 Diabetes Mellitus and Attributable Risk Factors in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Iranian Journal of Public Health (2024)
42. Iran Diabetes Research Roadmap (Idrr) Study; Nutrition in Diabetes: A Review Article, Iranian Journal of Public Health (2017)
43. Iran Diabetes Research Roadmap (Idrr) Study; Trends of Basic Sciences Publication: A Review Article, Iranian Journal of Public Health (2017)